HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 12, December 2018 – The story of WeDoctor - The medical service system for tomorrow       » World's first unmanned clinic in China       » International outcry over world's first gene-edited babies born in China       » More HIV-positive foreigners enter China       » Pain-free childbirth to be promoted in China       » The past, present and future of life science      
EYE ON CHINA
Genetically modified Zika virus vaccine to treat brain tumour
Researchers injected a live attenuated Zika virus vaccine in mice with glioblastoma or primary brain tumour, which significantly reduced the size of tumours

The recent Zika epidemics in the Americas have caused a global public health emergency, but researchers from China and the U.S. have made another discovery: a Zika virus vaccine they developed can inhibit brain tumor growth.

The ScienceNet.cn reported the new study which had been published earlier by mBio, a journal of the American Society for Microbiology.

According to the report, the joint study was led by Qin Chengfeng from the Academy of Military Medical Sciences in China, Man Jianghong from the National Center of Biomedical Analysis in China and Shi Peiyong from the University of Texas.

Glioblastoma (GBM) is the most common and malignant form of primary brain tumour. Treatment with surgery, radiation and chemotherapy have limited effect, and the recurrence rate is almost 100 percent. The average survival time of patients is about 14 months.

Previous studies found that the GBM stem cells played a key role in the development and recurrence of the fatal brain disease.

In 2017, researchers from the Academy of Military Medical Sciences in China and the University of Texas discovered that the Zika virus could infect and kill neural precursor cells and neural stem cells. And then, they developed a genetically modified live attenuated Zika virus vaccine (ZIKV-LAV).

They hypothesised that the Zika virus could also kill GBM stem cells, which have similar properties to neural stem cells.

Researchers injected the ZIKV-LAV into mice, and it did not cause any abnormal behaviours or damage to the brain and other organs, indicating that the vaccine was safe.

Then, they found that the tumour sizes were significantly reduced, and GBM stem cells were infected and killed in the brains of mice. Healthy cells were not harmed.

After further gene analysis, researchers found the mechanism of how the Zika virus works: The virus infection triggered a strong antiviral response, which elicited inflammation that killed GBM stem cells.

In experiments, the Zika virus also prolonged survival time of mice.

Zika virus is spread mostly through the bite of an infected Aedes mosquito. It can be passed on by a pregnant woman to her baby.

According to researchers, the study offers a new treatment for brain tumours, and they plan to work with clinicians to test the efficacy and safety of the vaccine in patients.

Source: Xinhua

Click here for the complete issue.

NEWS CRUNCH  
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management - Technologies for biotech and pharmaceutical industries
August:
Regenerative technology - Meat of the future
September:
Doctor Robot - The digital healthcare revolution
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy